-
Bezisterim may help with some Long COVID symptoms, drug’s developer reports in early trial results
While the phase 2 clinical trial results, shared by BioVie in a webinar on Tuesday, have yet to be peer-reviewed, investigators say they can inform a confirmatory phase 3 trial. Read more…
Recent articles
Get the latest Long COVID news and commentary
Processing…
Success! You're on the list.
Whoops! There was an error and we couldn't process your subscription. Please reload the page and try again.
Check out our weekly podcast, Still Here
Spotify
Apple Podcasts
PocketCasts
iHeartRadio
RSSTrending
Policy & Advocacy
-
Long COVID is significantly underreported across the globe
-
Alice Wong showed us Disability Justice makes our advocacy stronger
-
“Not a whole lot of substance”: HHS posts Long COVID website, six months after making big promises
-
Austin recognizes Long COVID Awareness Day, events happen around the world
-
Los Angeles recognizes Long COVID Awareness Day
-
Maryland considers Long COVID innovation bill
Science
Covid-19
Health
-
Breaking the vicious cycle: How two German scientists seek to solve ME
-
RECOVER’s first round of clinical trials are failing. Will the next phase be better?
-
A test for Long COVID can’t leave anyone behind
-
“People are dying because of the stigma”: Long COVID’s global underreporting problem
-
Emma Raducanu has post-viral syndrome. And commentators are giving her terrible advice.
-
We need masks in healthcare. Now.
